PUBLISHER: TechNavio | PRODUCT CODE: 1748530
PUBLISHER: TechNavio | PRODUCT CODE: 1748530
The non-invasive glucose monitoring devices market is forecasted to grow by USD 43.7 mn during 2024-2029, accelerating at a CAGR of 20.4% during the forecast period. The report on the non-invasive glucose monitoring devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of diabetes and initiatives by governments, frequent launch of non-invasive glucose monitoring devices, and increasing demand for non-invasive procedures.
Market Scope | |
---|---|
Base Year | 2025 |
End Year | 2029 |
Series Year | 2025-2029 |
Growth Momentum | Accelerate |
YOY 2025 | 16.8% |
CAGR | 20.4% |
Incremental Value | $43.7 mn |
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's non-invasive glucose monitoring devices market is segmented as below:
By Product
By End-user
By Component
By Geographical Landscape
This study identifies the growing focus on collaborations for business expansion as one of the prime reasons driving the non-invasive glucose monitoring devices market growth during the next few years. Also, integration of ai and radar technology in glucose monitoring and growing funding for non-invasive glucose monitoring technology will lead to sizable demand in the market.
The report on the non-invasive glucose monitoring devices market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading non-invasive glucose monitoring devices market vendors that include Abbott Laboratories, Ascensia Diabetes Care Holdings AG, BlueSemi, BoydSense SAS, Cnoga, Dexcom Inc., DiaMonTech AG, ESER Co., F. Hoffmann La Roche Ltd., Gluco Rx Ltd., HAGAR, LifeScan IP Holdings LLC, Medtronic Plc, Nemaura Medical Inc., NOVIOSENSE BV, Persperion Diagnostics, Senseonics Holdings Inc., and Taiwan Biophotonic Co.. Also, the non-invasive glucose monitoring devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Exhibits: